“vaccines” Archives

in
Entry Author Date Location
Elanco Boosts Vaccine Portfolio With $60M Prevtec Acquisition 08/01/19 Indiana
Neon’s Early Vaccine Study Is a Peek at Immunotherapy’s Third Wave 07/15/19 Boston
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Four More Through the IPO Door as Life Science Firms Raise $465M 06/20/19 National
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More 05/31/19 National
The Biotech IPO Queue Grows Longer as Five More Companies File 05/28/19 National
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More 02/01/19 National
Pfizer, GSK to Merge Consumer Health Units, Focus on Prescription Drugs 12/19/18 National
Moderna Raises $604M and Nails Down Biotech’s Biggest IPO Ever 12/06/18 Boston
Elanco IPO Raises $1.5B as the Animal Health Biz Spins Off from Lilly 09/20/18 Indiana
With BioNTech Deal, Pfizer Becomes Latest to Bet on mRNA Vaccines 08/16/18 New York
Elanco’s IPO Would Free Eli Lilly to Focus on Pharmaceuticals 08/03/18 Indiana
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines 06/11/18 Boston
Moderna’s Billions: Will Building Big Before an IPO Pay Off? 05/09/18 Boston
Moderna, Still Private, Scoops Up Yet Another $500M 02/01/18 Boston
Dynavax Co-founder Takes Long View on Vaccine Development 12/05/17 San Diego
Amid Cash Crunch, Genocea to Dump Herpes Vaccine, Focus on Cancer Work 09/25/17 Boston
Sanofi Shores Up Flu Vaccine Business With Protein Sciences Deal 07/11/17 New York
Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal 06/12/17 Boston
SRI’s Michigan Office Will Help Develop New VEE Vaccine 05/15/17 Detroit Ann Arbor
FDA Nominee Scott Gottlieb To Anti-Vaccine Crowd: Get Over It 04/05/17 National
How Battling New Epidemics Helps Fight Age-Old Killers 04/03/17 Seattle
Sanofi’s Experience With Dengvaxia May Speed Development of Zika Vaccine 11/04/16 Boston
Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More 10/07/16 National
Elanco Reaches $885M Deal for Boehringer’s Pet Vaccines Portfolio 10/05/16 Indiana
Genocea Touts Early Look at Placebo-Controlled Herpes Vaccine Study 09/29/16 Boston
Roundup: S3 Ventures, TMCx, George Peoples, Disruptors in Houston 08/25/16 Texas
FluGen Starts Clinical Trial for Universal Flu Vaccine 07/27/16 Wisconsin
The Outbreaks Are Here, Where’s Our Response Plan? 07/25/16 Seattle
Page 1 of 10 next page »